Jan'05 | Jan'06 | Jan'07 | Jan'08 | Jan'09 | Jan'10 | Jan'11 | Jan'12 | Jan'13 | Jan'14 | Jan'15 | Jan'16 | Jan'17 | Jan'18 | Jan'19 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($50.2M) | ($37.7M) | ($67.9M) | ($34.3M) | ($2,925.9K) | ($15.5M) | ($8,236.4K) | ($5,138.1K) | ($8,462.5K) | ($5,502.9K) | ($25.5M) | ($33.1M) | ($44.1M) | ($63.4M) | ($46.2M) | ($64.5M) | ($66.0M) | ($69.4M) | $170.2M | ($80.1M) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Summit Therapeutics Inc.'s last 12-month Net Debt is ($454.4M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Summit Therapeutics Inc.'s Net Debt growth was 392.4%. The average annual Net Debt growth rates for Summit Therapeutics Inc. have been 114.8% over the past three years, 83.0% over the past five years.
Over the last year, Summit Therapeutics Inc.'s Net Debt growth was 392.4%, which is higher than industry growth of (0.1%). It indicates that Summit Therapeutics Inc.'s Net Debt growth is Bad.